REG1A and MODY: ROC analysis on all data with the exclusion of the two patients with extreme hsCRP levels demonstrated that PSP/reg1A showed 90% sensitivity in identifying HNF1A-MODY patients, but with reduced specificity (67%) (Additional file 1: Figure S1B).